Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UCI researchers create new technique for speeding development of vaccines against infectious diseases

25.01.2005


Each spot on the microchip is a different protein. The bright colors indicate reactivity with serum antibodies.


Research responds to need for protection against potential bioweapons

A new technique devised by UC Irvine researchers can greatly facilitate the development of vaccines against infectious diseases such as smallpox, malaria and tuberculosis. Because the new technique can synthesize a large number of proteins very quickly, it has potential to accelerate vaccine development, particularly crucial in the fight against bioterrorism.

The technique is based on “polymerase chain reaction,” or PCR, and enables the rapid discovery of antigens for vaccines by allowing hundreds of proteins to be processed simultaneously using ordinary laboratory procedures. This new method allows the expression of 384 individual genes – pieces of DNA that contain instructions for making proteins – from a microorganism in just one week. Traditional methods take weeks to produce one protein at a time.



The UCI technique involves loading a microchip with every protein from an infectious microorganism such as smallpox, tuberculosis or malaria. When people infected with the disease react to some of the proteins included in the microchip, laser technology is used to identify these proteins for potential use in vaccines.

The researchers describe their technique in the Jan. 18, 2005 issue of the Proceedings of the National Academy of Sciences. “Technologies today are not able to quickly process large amounts of data that arrive in the form of genome sequences from many human pathogens,” said D. Huw Davies, lead author of the paper and associate project scientist in UCI’s Center for Virus Research. “Our technique addresses and removes this bottleneck. Remarkably, in only ten weeks, we can make every protein of an organism such as the tuberculosis bacterium – which has 3,900 genes.”

The researchers used their technique to identify a unique set of 11 proteins among a total of 200 proteins that make up the live virus that is used to vaccinate against smallpox today. Humans react strongly only to these 11 proteins, explained Philip Felgner, principal investigator of the research project and director of the proteomics laboratory within the Center for Virus Research. “Our method allows us to quickly identify which proteins are responsible for the protective immune response,” said Felgner, a co-author of the PNAS paper.
Scientists currently consider developing a safe vaccine to be the best way to blunt a bioterrorist threat against smallpox and other dangerous organisms that terrorists can use as weapons. “The existing live-virus vaccine against smallpox produces unacceptable side effects such as allergic reactions, sores, heart inflammation and angina,” Felgner said. “For a vaccine to be an effective defense against bioterrorism, however, it needs also to be safe. With our method, researchers can arrive very quickly at good vaccine candidates that are also extremely safe.”

The research, supported by grants from the National Institute of Allergy and Infectious Diseases, was conducted in Felgner’s proteomics laboratory. The laboratory belongs to a group of UCI biodefense laboratories developing vaccines and other countermeasures that target infectious microorganisms.

Additional co-authors of the PNAS paper are Xiaowu Liang, Jenny E. Hernandez, Arlo Randall, Siddiqua Hirst, Yunxiang Mu, Kimberly M. Romero, Toai T. Nguyen, Mina Kalantari-Dehaghi, Pierre Baldi and Luis P. Villarreal of UCI, as well as Shane Crotty of the La Jolla Institute for Allergy and Immunology.

UCI’s Center for Virus Research in the School of Biological Sciences seeks to foster interdisciplinary scholarship, training and research among UCI faculty by using molecular virology as a foundation for the creation of scientific resources. The center also promotes university-industry collaborations. Current research at the center includes vaccine antigen discovery and the testing of vaccines that use the discovered antigens.

About the University of California, Irvine: The University of California, Irvine is a top-ranked public university dedicated to research, scholarship and community service. Founded in 1965, UCI is among the fastest-growing University of California campuses, with more than 24,000 undergraduate and graduate students and about 1,400 faculty members. The second-largest employer in dynamic Orange County, UCI contributes an annual economic impact of $3 billion.

Iqbal Pittalwala | EurekAlert!
Further information:
http://www.uci.edu

More articles from Life Sciences:

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

nachricht The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>